All Stories

  1. Recent Evidence in Epigenomics and Proteomics Biomarkers for Early and Minimally Invasive Diagnosis of Alzheimer’s and Parkinson’s Diseases

    Article • Current Neuropharmacology, August 2021, Bentham Science Publishers

    Carmen Peña, Julián Benito León

  2. Omics-based Biomarkers for the Early Alzheimer Disease Diagnosis and Reliable Therapeutic Targets Development

    Article • Current Neuropharmacology, June 2019, Bentham Science Publishers

    Carmen Peña